Andreas Schlicker
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
Journal: Cancer research
Published: November 19, 2025
Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects.
Journal: Cancer discovery
Published: November 19, 2024
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.
Journal: International journal of molecular sciences
Published: November 13, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Journal: Cell chemical biology
Published: September 18, 2023
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 23, 2022
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model.
Journal: International journal of molecular sciences
Published: November 09, 2022
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2021
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Journal: Cancer discovery
Published: June 19, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Journal: International journal of cancer
Published: November 23, 2019
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models.
Journal: Molecular cancer therapeutics
Published: January 14, 2019
Last Updated: 09/26/2026